title: Characterization of the binding site for a novel class of noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonists.
abstract: The alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor is an ionotropic glutamate receptor that mediates fast excitatory synaptic transmission throughout the central nervous system. In addition to the glutamate binding site, allosteric modulatory sites on the receptor are inferred from the ability of synthetic compounds to affect channel function without interaction with the glutamate binding site. We have identified a novel class of potent, noncompetitive AMPA receptor antagonists typified by CP-465, 022 and CP-526,427. The latter compound was radiolabeled and used to elucidate the pharmacology of one allosteric modulatory site. [(3)H]CP-526,427 labels a single binding site in rat forebrain membranes with a K(d) value of 3.3 nM and a B(max) of 7.0 pmol/mg of protein. The [(3)H]CP-526,427 binding site does not seem to interact directly with the glutamate binding site but overlaps with that for another class of AMPA receptor antagonists, the 2,3-benzodiazepines. This binding site is distinct from that for the antagonist Evans blue and for several classes of compounds that modulate AMPA receptor desensitization. These results indicate the existence of at least two physically distinct allosteric sites on the AMPA receptor through which channel activity or desensitization is modulated.
authors.affiliation: Pfizer Global Research and Development, Groton, Connecticut, USA. mennitifs@groton.pfizer.com
authors.forename: F S
authors.initials: FS
authors.lastname: Menniti
authors.forename: B L
authors.initials: BL
authors.lastname: Chenard
authors.forename: M B
authors.initials: MB
authors.lastname: Collins
authors.forename: M F
authors.initials: MF
authors.lastname: Ducat
authors.forename: M L
authors.initials: ML
authors.lastname: Elliott
authors.forename: F E
authors.initials: FE
authors.lastname: Ewing
authors.forename: J I
authors.initials: JI
authors.lastname: Huang
authors.forename: K A
authors.initials: KA
authors.lastname: Kelly
authors.forename: J T
authors.initials: JT
authors.lastname: Lazzaro
authors.forename: M J
authors.initials: MJ
authors.lastname: Pagnozzi
authors.forename: J L
authors.initials: JL
authors.lastname: Weeks
authors.forename: W M
authors.initials: WM
authors.lastname: Welch
authors.forename: W F
authors.initials: WF
authors.lastname: White
mesh_terms: D000818:Animals; D001665:Binding Sites; D002118:Calcium / Q000378:metabolism; D066298:In Vitro Techniques; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D011799:Quinazolines / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors*
chemical_list: C418043:CP 526,427; D011799:Quinazolines; D018091:Receptors, AMPA; C418042:CP 465,022; D002118:Calcium